PRKACA and hepatocellular carcinoma: Of note, by using transcriptome sequencing, a recurrent chimeric transcript DNAJB1-PRKACA [13] was identified in fibrolamellar HCC (FL-HCC) patients, suggesting that this fusion transcript contributes to the pathogenesis of the FL-HCC and may represent a therapeutic target.